Table 2.
Method | N SNPs | ORa | 95% CI | P value |
---|---|---|---|---|
Coronary artery disease | ||||
Inverse variance weighted | 17 | 1.03 | (0.71–1.50) | 0.875 |
Weighted median | 17 | 0.94 | (0.57–1.54) | 0.800 |
MR Egger | 17 | 1.81 | (0.31–10.61) | 0.512 |
MR PRESSO | 17 | 1.03 | (0.71–1.49) | 0.877 |
Myocardial infarction | ||||
Inverse variance weighted | 17 | 1.16 | (0.74–1.80) | 0.519 |
Weighted median | 17 | 1.28 | (0.74–2.23) | 0.375 |
MR Egger | 17 | 1.57 | (0.19–12.97) | 0.676 |
MR PRESSO | 17 | 1.16 | (0.74–1.80) | 0.527 |
Ischemic stroke | ||||
Inverse variance weighted | 17 | 1.16 | (0.80–1.67) | 0.436 |
Weighted median | 17 | 1.15 | (0.71–1.87) | 0.565 |
MR Egger | 17 | 1.51 | (0.26–8.74) | 0.649 |
MR PRESSO | 17 | 1.16 | (0.86–1.55) | 0.340 |
MR PRESSO MR Pleiotropy RESidual Sum and Outlie, CI confidence interval, MET metabolic equivalent tasks
aOR (odds ratio) per increase in MET/h per week for self-reported physical activity